|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Marketable securities | ||||||||||||||||||||
| Accounts receivable | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Prepaid expense | ||||||||||||||||||||
| Other receivable | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Derivative liabilities | ||||||||||||||||||||
| Current portion of convertible notes - net of discount of $0 and $52,592 | ||||||||||||||||||||
| Convertible notes | ||||||||||||||||||||
| Notes Payable | ||||||||||||||||||||
| Note payable - related party | ||||||||||||||||||||
| Total note payable - related party | ||||||||||||||||||||
| Stock payable | ||||||||||||||||||||
| Due to related party | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Preferred stock value | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series C Preferred Stock | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Common stock ($.0001 par value, 1,250,000,000 shares authorized; 36,595,174 and 12,008,725 shares issued and outstanding as of June 30, 2026 and December 31, 2025, and 66 issuable, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Subscription receivable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total Stockholders' Deficit | ||||||||||||||||||||
| TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT | ||||||||||||||||||||
Loading...
